Loading...

CeriBell, Inc.

CBLLNASDAQ
Healthcare
Medical - Devices
$21.18
$0.12(0.57%)
U.S. Market opens in 30h 21m

CeriBell, Inc. Fundamental Analysis

CeriBell, Inc. (CBLL) shows moderate financial fundamentals with a PE ratio of -14.81, profit margin of -59.97%, and ROE of -31.77%. The company generates $0.1B in annual revenue with strong year-over-year growth of 44.71%.

Key Strengths

Cash Position20.20%
PEG Ratio-0.17
Current Ratio9.73

Areas of Concern

ROE-31.77%
Operating Margin-65.57%
We analyze CBLL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -29.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-29.9/100

We analyze CBLL's fundamental strength across five key dimensions:

Efficiency Score

Weak

CBLL struggles to generate sufficient returns from assets.

ROA > 10%
-27.28%

Valuation Score

Excellent

CBLL trades at attractive valuation levels.

PE < 25
-14.81
PEG Ratio < 2
-0.17

Growth Score

Moderate

CBLL shows steady but slowing expansion.

Revenue Growth > 5%
44.71%
EPS Growth > 10%
-2.09%

Financial Health Score

Excellent

CBLL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
9.73

Profitability Score

Weak

CBLL struggles to sustain strong margins.

ROE > 15%
-3177.14%
Net Margin ≥ 15%
-59.97%
Positive Free Cash Flow
No

Key Financial Metrics

Is CBLL Expensive or Cheap?

P/E Ratio

CBLL trades at -14.81 times earnings. This suggests potential undervaluation.

-14.81

PEG Ratio

When adjusting for growth, CBLL's PEG of -0.17 indicates potential undervaluation.

-0.17

Price to Book

The market values CeriBell, Inc. at 5.09 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.09

EV/EBITDA

Enterprise value stands at -16.21 times EBITDA. This is generally considered low.

-16.21

How Well Does CBLL Make Money?

Net Profit Margin

For every $100 in sales, CeriBell, Inc. keeps $-59.97 as profit after all expenses.

-59.97%

Operating Margin

Core operations generate -65.57 in profit for every $100 in revenue, before interest and taxes.

-65.57%

ROE

Management delivers $-31.77 in profit for every $100 of shareholder equity.

-31.77%

ROA

CeriBell, Inc. generates $-27.28 in profit for every $100 in assets, demonstrating efficient asset deployment.

-27.28%

Following the Money - Real Cash Generation

Operating Cash Flow

CeriBell, Inc. generates limited operating cash flow of $-41.42M, signaling weaker underlying cash strength.

$-41.42M

Free Cash Flow

CeriBell, Inc. generates weak or negative free cash flow of $-42.33M, restricting financial flexibility.

$-42.33M

FCF Per Share

Each share generates $-1.12 in free cash annually.

$-1.12

FCF Yield

CBLL converts -5.26% of its market value into free cash.

-5.26%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-14.81

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.17

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.98

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

9.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.32

vs 25 benchmark

ROA

Return on assets percentage

-0.27

vs 25 benchmark

ROCE

Return on capital employed

-0.33

vs 25 benchmark

How CBLL Stacks Against Its Sector Peers

MetricCBLL ValueSector AveragePerformance
P/E Ratio-14.8128.81 Better (Cheaper)
ROE-31.77%643.00% Weak
Net Margin-59.97%-44312.00% (disorted) Weak
Debt/Equity0.140.36 Strong (Low Leverage)
Current Ratio9.734.50 Strong Liquidity
ROA-27.28%-17799.00% (disorted) Weak

CBLL outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CeriBell, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

88.70%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

18.64%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

18.15%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ